REFERENCES

1. Rogers RG, Everett BG, Onge JM, Krueger PM. Social, behavioral, and biological factors, and sex differences in mortality. Demography 2010;47:555-78.

2. Blair ML. Sex-based differences in physiology: what should we teach in the medical curriculum? Adv Physiol Educ 2007;31:23-5.

3. Narla RR, Ott SM. Bones and the sex hormones. Kidney Int 2018;94:239-42.

4. Mayes JS, Watson GH. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev 2004;5:197-216.

5. Vitale C, Mendelsohn ME, Rosano GM. Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol 2009;6:532-42.

6. Lee C, Kim J, Jung Y. Potential therapeutic application of estrogen in gender disparity of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Cells 2019;8:1259.

7. Sukocheva OA, Wee C, Ansar A, Hussey DJ, Watson DI. Effect of estrogen on growth and apoptosis in esophageal adenocarcinoma cells. Dis Esophagus 2013;26:628-35.

8. Sukocheva OA, Li B, Due SL, Hussey DJ, Watson DI. Androgens and esophageal cancer: what do we know? World J Gastroenterol 2015;21:6146-56.

9. Liu Z, Zhang Y, Lagergren J, et al. Circulating sex hormone levels and risk of gastrointestinal cancer: systematic review and meta-analysis of prospective studies. Cancer Epidemiol Biomarkers Prev 2023;32:936-46.

10. Yang X, Schadt EE, Wang S, et al. Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res 2006;16:995-1004.

11. Sayaf K, Gabbia D, Russo FP, De Martin S. The role of sex in acute and chronic liver damage. Int J Mol Sci 2022;23:10654.

12. Francavilla A, Polimeno L, DiLeo A, et al. The effect of estrogen and tamoxifen on hepatocyte proliferation in vivo and in vitro. Hepatology 1989;9:614-20.

13. Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010;51:1972-8.

14. Yang JD, Abdelmalek MF, Pang H, et al. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. Hepatology 2014;59:1406-14.

15. Liu P, Xie SH, Hu S, et al. Age-specific sex difference in the incidence of hepatocellular carcinoma in the United States. Oncotarget 2017;8:68131-7.

16. Harris HE, Ramsay ME, Andrews N, Eldridge KP. HCV National Register Steering Group.Hepatitis C virus. Clinical course of hepatitis C virus during the first decade of infection: cohort study. BMJ 2002;324:450-3.

17. Fedeli U, Avossa F, Ferroni E, De Paoli A, Donato F, Corti MC. Prevalence of chronic liver disease among young/middle-aged adults in Northern Italy: role of hepatitis B and hepatitis C virus infection by age, sex, ethnicity. Heliyon 2019;5:e02114.

18. Eguchi Y, Hyogo H, Ono M, et al. JSG-NAFLD. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol 2012;47:586-95.

19. Wands J. Hepatocellular carcinoma and sex. N Engl J Med 2007;357:1974-6.

20. López-Luque J, Fabregat I. Revisiting the liver: from development to regeneration-what we ought to know! Int J Dev Biol 2018;62:441-51.

21. Sayiner M, Younossi ZM. Nonalcoholic steatohepatitis is becoming a top indication for liver transplantation worldwide. Liver Transpl 2019;25:10-1.

22. Hermann HC, Klapp BF, Danzer G, Papachristou C. Gender-specific differences associated with living donor liver transplantation: a review study. Liver Transpl 2010;16:375-86.

23. Waki K. UNOS liver registry: ten year survivals. Clin Transpl 2006:29-39.

24. Guy J, Peters MG. Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes. Gastroenterol Hepatol 2013;9:633-9.

25. Birrer DL, Linecker M, López-López V, et al. Sex disparities in outcomes following major liver surgery: new powers of estrogen? Ann Surg 2022;276:875-81.

26. Francavilla A, Gavaler JS, Makowka L, et al. Estradiol and testosterone levels in patients undergoing partial hepatectomy. A possible signal for hepatic regeneration? Dig Dis Sci 1989;34:818-22.

27. Francavilla A, Eagon PK, DiLeo A, et al. Sex hormone-related functions in regenerating male rat liver. Gastroenterology 1986;91:1263-70.

28. Wang Y, Ye F, Ke Q, Wu Q, Yang R, Bu H. Gender-dependent histone deacetylases injury may contribute to differences in liver recovery rates of male and female mice. Transplant Proc 2013;45:463-73.

29. Desbois-Mouthon C, Wendum D, Cadoret A, et al. Hepatocyte proliferation during liver regeneration is impaired in mice with liver-specific IGF-1R knockout. FASEB J 2006;20:773-5.

30. Liddle C, Hollands M, Little JM, Farrell GC. The effects of partial hepatectomy on serum sex steroids in humans. Hepatology 1992;15:623-8.

31. Uebi T, Umeda M, Imai T. Estrogen induces estrogen receptor alpha expression and hepatocyte proliferation in the livers of male mice. Genes Cells 2015;20:217-23.

32. Mullany LK, Hanse EA, Romano A, et al. Cyclin D1 regulates hepatic estrogen and androgen metabolism. Am J Physiol Gastrointest Liver Physiol 2010;298:G884-95.

33. Umeda M, Hiramoto M, Imai T. Partial hepatectomy induces delayed hepatocyte proliferation and normal liver regeneration in ovariectomized mice. Clin Exp Gastroenterol 2015;8:175-82.

34. Zhou Y, Zhang L, Ji H, et al. MiR-17~92 ablation impairs liver regeneration in an estrogen-dependent manner. J Cell Mol Med 2016;20:939-48.

35. Batmunkh B, Choijookhuu N, Srisowanna N, et al. Estrogen accelerates cell proliferation through estrogen receptor α during rat liver regeneration after partial hepatectomy. Acta Histochem Cytochem 2017;50:39-48.

36. Marubashi S, Dono K, Nagano H, et al. Postoperative hyperbilirubinemia and graft outcome in living donor liver transplantation. Liver Transpl 2007;13:1538-44.

37. Kao TL, Chen YL, Kuan YP, et al. Estrogen-Estrogen receptor α signaling facilitates bilirubin metabolism in regenerating liver through regulating cytochrome P450 2A6 expression. Cell Transplant 2017;26:1822-9.

38. Castellaneta A, Di Leo A, Francavilla R, et al. Functional modification of CD11c+ liver dendritic cells during liver regeneration after partial hepatectomy in mice. Hepatology 2006;43:807-16.

39. Dixit A, Baquer NZ, Rao AR. Effect of 17 beta-estradiol and ovariectomy on enzymes of carbohydrate metabolism in regenerating mouse liver. Biochem Int 1991;24:649-59.

40. Srisowanna N, Choijookhuu N, Yano K, et al. The Effect of estrogen on hepatic fat accumulation during early phase of liver regeneration after partial hepatectomy in rats. Acta Histochem Cytochem 2019;52:67-75.

41. Nemoto Y, Toda K, Ono M, et al. Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. J Clin Invest 2000;105:1819-25.

42. Pighon A, Gutkowska J, Jankowski M, Rabasa-Lhoret R, Lavoie JM. Exercise training in ovariectomized rats stimulates estrogenic-like effects on expression of genes involved in lipid accumulation and subclinical inflammation in liver. Metabolism 2011;60:629-39.

43. Kuiper GG, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997;138:863-70.

44. Kao TL, Kuan YP, Cheng WC, et al. Estrogen receptors orchestrate cell growth and differentiation to facilitate liver regeneration. Theranostics 2018;8:2672-82.

45. Yager JD, Zurlo J, Sewall CH, Lucier GW, He H. Growth stimulation followed by growth inhibition in livers of female rats treated with ethinyl estradiol. Carcinogenesis 1994;15:2117-23.

46. Koroxenidou L, Ohlson LC, Porsch Hällström I. Long-term 17alpha-ethinyl estradiol treatment decreases cyclin E and cdk2 expression, reduces cdk2 kinase activity and inhibits S phase entry in regenerating rat liver. J Hepatol 2005;43:478-84.

47. Yamamoto Y, Moore R, Hess HA, et al. Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity. J Biol Chem 2006;281:16625-31.

48. Chaturantabut S, Shwartz A, Evason KJ, et al. Estrogen activation of G-Protein-Coupled estrogen receptor 1 regulates phosphoinositide 3-Kinase and mTOR signaling to promote liver growth in zebrafish and proliferation of human hepatocytes. Gastroenterology 2019;156:1788-1804.e13.

Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/